Finder's Pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Magellan Health is a healthcare plans business based in the US. Magellan Health stocks (MGLN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Magellan Health employs 9,000 staff and has a trailing 12-month revenue of around $4.8 billion.
|Latest market close||$0.00|
|52-week range||$82.94 - $99.36|
|50-day moving average||$94.68|
|200-day moving average||$94.47|
|Wall St. target price||$95.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$11.19|
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2022-01-17)||nan%|
|1 month (2021-12-27)||-100.00%|
|3 months (2021-10-24)||nan%|
|6 months (2021-07-28)||-100.00%|
|1 year (2021-01-28)||-100.00%|
|2 years (2020-01-28)||-100.00%|
|3 years (2019-01-28)||64.77|
|5 years (2017-01-27)||75.75|
Valuing Magellan Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Magellan Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Magellan Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Magellan Health shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Magellan Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.93. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Magellan Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Magellan Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $86.8 million.
The EBITDA is a measure of a Magellan Health's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4.8 billion|
|Operating margin TTM||0.6%|
|Gross profit TTM||$120.8 million|
|Return on assets TTM||0.54%|
|Return on equity TTM||-0.16%|
|Market capitalisation||$2.5 billion|
TTM: trailing 12 months
We're not expecting Magellan Health to pay a dividend over the next 12 months.
Magellan Health's shares were split on a 1:308 basis on 6 January 2004. So if you had owned 308 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Magellan Health shares – just the quantity. However, indirectly, the new 30700% higher share price could have impacted the market appetite for Magellan Health shares which in turn could have impacted Magellan Health's share price.
Over the last 12 months, Magellan Health's shares have ranged in value from as little as $82.94 up to $99.36. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Magellan Health's is 1.0353. This would suggest that Magellan Health's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Magellan Health, Inc. , together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions.
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Read our expert analysis on Kusama and how the token will perform in the future.
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.